Rejoinder
From MaRDI portal
Publication:5122848
DOI10.1002/BIMJ.200610258zbMATH Open1442.62420OpenAlexW4231183376MaRDI QIDQ5122848FDOQ5122848
Authors:
Publication date: 24 September 2020
Published in: Biometrical Journal (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1002/bimj.200610258
Recommendations
- Adaptive designs from the viewpoint of an academic biostatistician
- Methodological developments vs. regulatory requirements
- Opening the adaptive toolbox
- Challenges in implementing adaptive designs: comments on the viewpoints expressed by regulatory statisticians
- FDA's critical path initiative: a perspective on contributions of biostatistics
Cited In (16)
- Rejoinder
- Rejoinder
- Rejoinder
- Rejoinder
- Rejoinder
- Rejoinder
- Ephedra
- FDA's critical path initiative: a perspective on contributions of biostatistics
- Adaptive designs from the viewpoint of an academic biostatistician
- Challenges in implementing adaptive designs: comments on the viewpoints expressed by regulatory statisticians
- Opening the adaptive toolbox
- Methodological developments vs. regulatory requirements
- Rejoinder to Discussions on “Approval policies for modifications to machine learning‐based software as a medical device: A study of bio‐creep”
- Rejoinder
- Rejoinder
- Rejoinder
This page was built for publication: Rejoinder
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q5122848)
